Novadiscovery brings a unique in silico approach to the discovery and development of targeted therapies driven by the quantitative assessment of a compound's commercial relevance from the early phases of research.
The pharmaceutical industry is facing unprecedented upstream pressures – the innovation crisis, and downstream pressures – global fiscal imbalances and the resulting pressure to demonstrate patient outcomes, that will force a new landscape to emerge in the next 10 years.
Flexibility will determine the shape of successful business models in the new era, which will build on the ability to structure virtual pharma networks and implement asset-centric funding models to advance breakthrough research.
Novadiscovery is taking a transformative approach to new drug discovery and development, which adds significant value by increasing success rates, lowering development costs and achieving higher pricing and reimbursement points.
We apply our science and technology to R&D programs from discovery to market in the areas of cancer, immunology, cardiovascular and infectious diseases.
The company is operating a virtual platform on the back of a proprietary approach to predict a drug's efficacy by combining quantitative models of diseases with virtual populations of patients.
Novadiscovery’s disease models provide instant access to hundreds of potential targets validated by our in silico predictions. The efficiency of the model is highly attractive.
Our in silico drug discovery and development platform operates as a cost-efficient virtual pharma, with critical expertise externalized through a network of specialized servicers (computational chemistry, toxicity & safety studies, etc.).
Our projects build on a large set of heterogeneous skills to rise up to the challenges of biological complexity. Collaborations with academia, clinicians, experts and patients are critical to our research.
We are looking for partners who
Interested in partnering? Contact us at: email@example.com
Discover how our science and technology make a difference for patients in high unmet need areas.
Novadiscovery has an exciting pipeline of ongoing projects in high unmet needs areas, which will bring better treatments and target the right patients.
Browse our projects roster. If you have an interest in learning more about any of them or if you think you can contribute valuable expertise, contact us at: firstname.lastname@example.org
We believe time is ripe for a radical rethink of R&D to discover innovative and targeted therapies at an affordable cost.
Novadiscovery ambitions to blaze the trail of emerging business models where successful companies combine efficient operations with the ability to manage R&D risks and finance breakthrough innovation in a flexible way.
Unconventional research with an entrepreneurial drive
Our success ultimately depends on the quality of our human capital. We look for people with a passion for excellence, a belief in the power of the team, integrity and leadership.
Feedback & enquiries